BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 31, 2009
View Archived Issues
Freie Universitaet Berlin claims novel pepstatin A derivatives
Read More
CKD Pharmaceuticals describes discovery of PDE5 inhibitor CKD-533
Read More
Activity of nab-rapamycin against breast cancer xenografts enhanced by other agents
Read More
Synergistic growth inhibition seen with BEZ-235 and dual EGFR and HER-2/neu inhibitor
Read More
Novel Raf kinase inhibitors presented by Wyeth as oncolytics
Read More
Esteve discloses 5-HT6 receptor ligands for the treatment of eating disorders
Read More
Novel HDAC inhibitors being developed by EnVivo Pharmaceuticals and MethylGene
Read More
Pim kinase inhibitors claimed by Novartis for the treatment of cancer
Read More
Novel Raf kinase inhibitors described by Novartis for the treatment of cancer
Read More
Takeda discovers a novel series of AMPA glutamate receptor agonists
Read More
Phase I results suggest ARRY-380 is well tolerated, active in breast cancer patients
Read More
Novo Nordisk provides update on timeline for formal FDA feedback on liraglutide
Read More
Santarus submits IND for phase III rifamycin SV MMX trial
Read More
FDA accepts NDA filing for Valeant's retigabine
Read More
Pfizer discontinues phase III figitumumab trial in non-small cell lung cancer
Read More
FDA issues complete response letter for ceftobiprole
Read More
MedImmune voluntarily recalls specific lots of 2009 H1N1 nasal spray vaccine
Read More
FDA review of Vytorin deems cancer risk "unlikely"
Read More
FDA responds to Vion's SPA request regarding Onrigin
Read More
Biotec sells Immunocorp subsidiaries in order to focus on biopharmaceuticals
Read More
Meda expands collaboration for Axorid
Read More
Clinical study of NPC-1C begins for pancreatic and colorectal cancer
Read More
BGC-20-0134 moves into phase II investigation for relapsing remitting MS
Read More
LEO-29102 enters phase II study for atopic dermatitis
Read More
Merck identifies novel macrocyclic hepatitis C NS3/4A protease inhibitors
Read More